Back to search

Article

SETD2 Deficiency and miR-21: Potent Therapeutic Targets in NUT Midline Carcinoma

2021-09-20

Abstract excerpt

<h4>Background: </h4> Nuclear protein in testis (NUT) midline carcinoma (NMC) is a rare and highly aggressive tumor with the bromodomain containing 4 protein ( BRD4 ) -NUT ( NUTM1 ) gene fusion. Few targeted therapies are available for NMC, and novel therapeutic targets are required. The objectives of our study was to determine gene mutations and microRNA (miRNA) expression levels in NMC and to identify novel ther...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6acc5543-e920-584a-b9c4-fd268f0f8de3
DOI
10.21203/rs.3.rs-857889/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SETD2 Deficiency and miR-21: Potent Therapeutic Targets in NUT Midline CarcinomaDOI 10.21203/rs.3.rs-857889/v1
Select a neighboring publication to make it the new centre.